120 related articles for article (PubMed ID: 4044073)
1. Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
Rocher I; Decourt S; Leneveu A; Lebrec D; Rosier SP; Flouvat B
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):406-10. PubMed ID: 4044073
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
[TBL] [Abstract][Full Text] [Related]
3. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D
Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
5. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
6. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
Bandi JC; García-Pagán JC; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
[TBL] [Abstract][Full Text] [Related]
8. [Antianginal and hemodynamic effect of propranolol and atenolol in patients with exertion angina].
Desiatnichenko VM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):71-5. PubMed ID: 6508931
[TBL] [Abstract][Full Text] [Related]
9. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
10. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
11. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
Pozzi M; Grassi G; Ratti L; Favini G; Dell'Oro R; Redaelli E; Calchera I; Boari G; Mancia G
Am J Gastroenterol; 2005 May; 100(5):1110-6. PubMed ID: 15842586
[TBL] [Abstract][Full Text] [Related]
12. The hemodynamic response of cirrhotic patients to the combined administration of vasopressin and isoproterenol.
Sirinek KP; Thomford NR
Rev Surg; 1975; 32(3):217-20. PubMed ID: 1135607
[No Abstract] [Full Text] [Related]
13. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
Li S
Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
[TBL] [Abstract][Full Text] [Related]
14. Circadian bioavailability and some effects of propranolol in healthy subjects and in liver cirrhosis.
Semenowicz-Siuda K; Markiewicz A; Korczyńska-Wardecka J
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):653-8. PubMed ID: 6526540
[TBL] [Abstract][Full Text] [Related]
15. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
[TBL] [Abstract][Full Text] [Related]
16. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
[TBL] [Abstract][Full Text] [Related]
17. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
Hansson L
Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
[No Abstract] [Full Text] [Related]
19. Hemodynamic effects of a beta adrenergic blocking agent-atenolol in patients with severe mitral stenosis.
Thongtang V; Srivanasont N; Chaithiraphan S
J Med Assoc Thai; 1993 Jan; 76(1):9-16. PubMed ID: 8228697
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis.
Tonsuwannont W; Praisontarangkul OA; Manorot M; Klangwarnwong D
J Med Assoc Thai; 1996 May; 79(5):309-19. PubMed ID: 8708523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
